President Donald Trump’s Dec. 18 executive order directing the Justice Department to officially classify cannabis as a less-dangerous drug with medicinal value under federal law is historic and transformative. But marijuana rescheduling is also generating confusion, wild speculation and genuine misinformation in and around the $32 billion U.S. regulated cannabis industry. Read more »
Trump weighs executive order on cannabis restrictions
President Donald Trump could sign an executive order as soon as Thursday that would reclassify marijuana, potentially reshaping life for millions of Americans. The White House says the proposal is still under consideration, but it’s expected to reclassify marijuana from Schedule I to Schedule III under federal drug law. Read more »
Could CBD in Cannabis Help Protect the Livers of Heavy Drinkers?
A study of more than 66,000 U.S. adults finds that heavy drinkers who also used cannabis were less likely to develop liver disease than those who drank heavily without using weed. While the study authors were quick to say that this isn’t a recommendation to start smoking cannabis, the CBD component of the plant might help protect […]
Cannabis Marketed in SF Shops For Pain And Sleep Despite Lack of Clinical Evidence: UCSF
Walk into a Bay Area dispensary looking for help with an aching back or a restless night, and odds are the person behind the counter will steer you to a lotion or a gummy. A new UCSF study says that’s common — and that the advice often leans on personal experience more than clinical evidence. […]